Quantcast

Latest Bare-metal stent Stories

2014-09-16 08:29:53

-- Differentiated Design Yields Excellent Tissue Healing and Sustained Safety Profile -- DURHAM, N.C., Sept. 16, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced that three-year clinical results from the DESSOLVE I and DESSOLVE II trials of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®)) were presented at the 26th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference being held in Washington, D.C., September 13-17....

2014-07-21 16:26:15

Advanced Bare-Metal Stent Provides Additional Treatment Option for Interventional Cardiologists and Patients MARLBOROUGH, Mass., July 21, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received FDA approval for the REBEL(TM) Platinum Chromium Coronary Stent System, the company's latest generation bare-metal stent for the treatment of coronary artery disease (CAD). Bare-metal stents continue to play an important role in the treatment of CAD and represent a...

2014-07-09 08:28:18

-- Newly Issued US Patent Covers Medical Device Coating Process and Compositions -- DURHAM, N.C., July 9, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a patent related to Micell's technology for enhancing the performance of medical devices with precise drug-delivery coatings. These technologies currently are used in producing the company's drug-eluting stent system, MiStent SES(®). The...

2014-07-07 23:08:20

"Coronary Stents – Global Trends, Estimates, and Forecasts 2012-2018" and "Coronary Stents – Emerging Markets (Brazil, Russia, India, China, South Africa, and South Korea) 2012-2018" are new market research reports added to the ReportsnReports.com store. Dallas, TX (PRWEB) July 07, 2014 Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. North America accounts for nearly 41% (2015) of the global value, while Europe claims approximately 29%...

2014-07-01 16:29:47

LONDON and NEW YORK, July 1, 2014 /PRNewswire/ -- http://www.abmrg.com/India-Coronary-Stent-Market---Potential-and-Growth-Forecast-to-2019.html The coronary stent market in India was valued around $450 million in 2012 and it has grown at an impressive rate of 22% (2005-2012) backed by a rise in PCIs (Percutaneous Coronary Intervention) which is resulted from a surge in cardiovascular disease (CVD), an improvement in healthcare infrastructure and services and an increase...

2014-06-17 08:29:31

DUBLIN, June 17, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/h8c9j9/north_american) has announced the addition of the "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon, Stent, Catheter, IVC Filter, Endovascular Stent Graft - Forecast to 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The North American interventional cardiology devices market is expected to...

2014-05-26 12:23:12

DUBLIN, May 26, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wkbfxj/coronary_stents) has announced the addition of the "Global Coronary Stents (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 A coronary stent is a tubular structured device made of a thin mesh of wire, which may also be coated with a polymer containing a drug, or...

2014-05-23 08:23:56

-- Sustained Safety Profile -- DURHAM, N.C., May 23, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced that long-term clinical outcomes from its DESSOLVE I and II clinical trials were presented at the EuroPCR conference in Paris, France this week. Presentations by principal investigator William Wijns, M.D., Ph.D. of the Cardiovascular Center in Aalst, Belgium, highlighted results of long-term clinical follow-up of the MiStent Sirolimus Eluting Absorbable Polymer Coronary...

2014-05-15 16:28:10

-- Oral Presentations to Include New Long-Term Results from First-in-Human Study -- DURHAM, N.C., May 15, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced the updated three- and two-year clinical outcomes from its DESSOLVE I and II clinical trials, respectively, will be presented at the EuroPCR conference to be held in Paris, France from May 20 - 23. Two oral presentations will be made by William Wijns, M.D., Ph.D., Cardiovascular Center, Aalst, Belgium: -- DESSOLVE II...

2014-05-05 08:28:39

SINGAPORE, May 5, 2014 /PRNewswire/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, announced today that the U.S. Food and Drug Administration (FDA) recently granted conditional Investigational Device Exemption (IDE) approval for a U.S.-based clinical trial of the BioFreedom(TM) polymer-free drug-coated stent (DCS) system. The BioFreedom U.S....


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.